Lung cancer is a leading cause of mortality worldwide. The past two decades have shown dramatic advances in our understanding of molecular and genetic biomarkers that can predict both disease progression and responses to various treatments. These advances have led to significantly improved outcomes for many patients.
Lung cancers can be subdivided broadly into small cell or non–small cell carcinoma, with the latter comprising squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Signs and symptoms may vary depending on the tumor type and extent of metastases, while treatment and prognoses are closely tied to the type and stage of the tumor identified. Targeted therapeutics are emerging with specific indications beyond the scope of this course, but the basic workup should be understood by any aspiring physician.
5 Stars |
|
7 |
4 Stars |
|
0 |
3 Stars |
|
0 |
2 Stars |
|
0 |
1 Star |
|
0 |
Dr.Brown makes the concept very clear to understand,very essential
This lecture provides a good, general overview of deciding if a patient is a candidate for surgery. Though brief, it is much better explained than in review books.
This lecture provides a good overview of clinical signs and symptoms.
Great,Great,Great,Great,Great,Great,GreatGreat,Great,Great,Great